Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 145

1.

Matrix metalloproteinase-9 increases in the sputum from allergic occupational asthma patients after specific inhalation challenge.

Castano R, Miedinger D, Maghni K, Ghezzo H, Trudeau C, Castellanos L, Wattiez M, Vandenplas O, Malo JL.

Int Arch Allergy Immunol. 2013;160(2):161-4. doi: 10.1159/000339737. Epub 2012 Sep 25.

PMID:
23018543
2.

Distinct temporal patterns of immediate asthmatic reactions due to high- and low-molecular-weight agents.

Malo JL, Ghezzo H, L'archevêque J.

Clin Exp Allergy. 2012 Jul;42(7):1021-7. doi: 10.1111/j.1365-2222.2012.03970.x.

PMID:
22702501
3.

Matrix metalloproteinases and tissue inhibitors of metalloproteinases in nasal lavage after an inhalation challenge with flour.

Castano R, Miedinger D, Maghni K, Ghezzo H, Trudeau C, Castellanos L, Wattiez M, Vandenplas O, Malo JL.

Laryngoscope. 2012 Apr;122(4):730-5. doi: 10.1002/lary.23206. Epub 2012 Feb 28.

PMID:
22374842
4.

Feasibility of monitoring nasal and exhaled nitric oxide with a handheld analyzer during specific inhalation challenge.

Castano R, Miedinger D, Ghezzo H, Vandenplas O, Malo JL.

Ann Allergy Asthma Immunol. 2012 Jan;108(1):65-66. doi: 10.1016/j.anai.2011.10.008. Epub 2011 Nov 18. No abstract available.

PMID:
22192972
5.

Identification of clinically significant psychological distress and psychiatric morbidity by examining quality of life in subjects with occupational asthma.

Miedinger D, Lavoie KL, L'Archeveque J, Ghezzo H, Malo JL.

Health Qual Life Outcomes. 2011 Sep 22;9:76. doi: 10.1186/1477-7525-9-76.

6.

Direct costs of occupational asthma due to sensitization in Quebec (1988 to 2002): revisited.

Malo JL, Zunzunegui MV, L'Archevêque J, Cardinal S, Ghezzo H.

Can Respir J. 2011 Jan-Feb;18(1):e1-5.

7.

Quality-of-life, psychological, and cost outcomes 2 years after diagnosis of occupational asthma.

Miedinger D, Lavoie KL, L'Archevêque J, Ghezzo H, Zunzunuegui MV, Malo JL.

J Occup Environ Med. 2011 Mar;53(3):231-8. doi: 10.1097/JOM.0b013e31820d1338.

PMID:
21346630
8.

Exhaled nitric oxide and spirometry in respiratory health surveillance.

Bohadana AB, Hannhart B, Ghezzo H, Teculescu D, Zmirou-Navier D.

Occup Med (Lond). 2011 Mar;61(2):108-14. doi: 10.1093/occmed/kqq184. Epub 2011 Jan 31.

PMID:
21285029
9.
10.

Association of bronchial reactivity to occupational agents with methacholine reactivity, sputum cells and immunoglobulin E-mediated reactivity.

Malo JL, Cardinal S, Ghezzo H, L'Archevêque J, Castellanos L, Maghni K.

Clin Exp Allergy. 2011 Apr;41(4):497-504. doi: 10.1111/j.1365-2222.2010.03659.x. Epub 2010 Nov 29.

PMID:
21114694
11.

Does the methacholine test reproduce symptoms?

Lévesque M, Ghezzo H, L'Archevêque J, Malo JL.

Can Respir J. 2010 Sep-Oct;17(5):224-8.

12.

Factors discriminating spontaneous pursed-lips breathing use in patients with COPD.

Spahija J, Marchie Md, Ghezzo H, Grassino A.

COPD. 2010 Aug;7(4):254-61. doi: 10.3109/15412555.2010.496820.

PMID:
20673034
13.

Sites of allergic airway smooth muscle remodeling and hyperresponsiveness are not associated in the rat.

Siddiqui S, Jo T, Tamaoka M, Shalaby KH, Ghezzo H, Bernabeu M, Martin JG.

J Appl Physiol (1985). 2010 Oct;109(4):1170-8. doi: 10.1152/japplphysiol.01168.2009. Epub 2010 Jul 22.

14.

Factors influencing duration of exposure with symptoms and costs of occupational asthma.

Miedinger D, Malo JL, Ghezzo H, L'Archevêque J, Zunzunegui MV.

Eur Respir J. 2010 Oct;36(4):728-34. doi: 10.1183/09031936.00198209. Epub 2010 Feb 11.

15.

Airway remodeling in subjects with severe asthma with or without chronic persistent airflow obstruction.

Kaminska M, Foley S, Maghni K, Storness-Bliss C, Coxson H, Ghezzo H, Lemière C, Olivenstein R, Ernst P, Hamid Q, Martin J.

J Allergy Clin Immunol. 2009 Jul;124(1):45-51.e1-4. doi: 10.1016/j.jaci.2009.03.049. Epub 2009 May 29.

PMID:
19481790
16.

Long-term outcomes of acute irritant-induced asthma.

Malo JL, L'archevêque J, Castellanos L, Lavoie K, Ghezzo H, Maghni K.

Am J Respir Crit Care Med. 2009 May 15;179(10):923-8. doi: 10.1164/rccm.200810-1550OC. Epub 2009 Feb 20.

PMID:
19234102
17.

Direct costs of occupational asthma in Quebec between 1988 and 2002.

Malo JL, L'Archevêque J, Ghezzo H.

Can Respir J. 2008 Nov-Dec;15(8):413-6.

18.

The Dutch diagnostic model for laboratory animal allergen sensitization was generalizable in Canadian apprentices.

Suarthana E, Meijer E, Heederik D, Ghezzo H, Malo JL, Gautrin D.

J Clin Epidemiol. 2009 May;62(5):542-9. doi: 10.1016/j.jclinepi.2008.06.020. Epub 2008 Dec 12.

PMID:
19070461
19.

Specific antibodies to diisocyanate and work-related respiratory symptoms in apprentice car-painters.

Dragos M, Jones M, Malo JL, Ghezzo H, Gautrin D.

Occup Environ Med. 2009 Apr;66(4):227-34. doi: 10.1136/oem.2007.038125. Epub 2008 Nov 18.

PMID:
19017707
20.

Which tools best predict the incidence of work-related sensitisation and symptoms.

Suarthana E, Malo JL, Heederik D, Ghezzo H, L'Archevêque J, Gautrin D.

Occup Environ Med. 2009 Feb;66(2):111-7. doi: 10.1136/oem.2008.041079. Epub 2008 Nov 18. Erratum in: Occup Environ Med. 2009 Oct;66(10):711-2.

PMID:
19017704
21.

Risks for the development of outcomes related to occupational allergies: an application of the asthma-specific job exposure matrix compared with self-reports and investigator scores on job-training-related exposure.

Suarthana E, Heederik D, Ghezzo H, Malo JL, Kennedy SM, Gautrin D.

Occup Environ Med. 2009 Apr;66(4):256-63. doi: 10.1136/oem.2008.041962. Epub 2008 Nov 18.

PMID:
19017693
22.

Occupational rhinitis in workers investigated for occupational asthma.

Castano R, Gautrin D, Thériault G, Trudeau C, Ghezzo H, Malo JL.

Thorax. 2009 Jan;64(1):50-4. doi: 10.1136/thx.2008.102822. Epub 2008 Oct 3.

PMID:
18835961
23.

Comparison of lung morphology in COPD secondary to cigarette and biomass smoke.

Rivera RM, Cosio MG, Ghezzo H, Salazar M, Pérez-Padilla R.

Int J Tuberc Lung Dis. 2008 Aug;12(8):972-7.

PMID:
18647460
24.

Reproducibility of nasal lavage in the context of the inhalation challenge investigation of occupational rhinitis.

Castano R, Thériault G, Maghni K, Ghezzo H, Malo JL, Gautrin D.

Am J Rhinol. 2008 May-Jun;22(3):271-5. doi: 10.2500/ajr.2008.22.3165.

PMID:
18588759
25.

Long-term outcomes in a prospective cohort of apprentices exposed to high-molecular-weight agents.

Gautrin D, Ghezzo H, Infante-Rivard C, Magnan M, L'archevêque J, Suarthana E, Malo JL.

Am J Respir Crit Care Med. 2008 Apr 15;177(8):871-9. doi: 10.1164/rccm.200707-991OC. Epub 2008 Jan 24.

PMID:
18218991
26.

Reproducibility of acoustic rhinometry in the investigation of occupational rhinitis.

Castano R, Thériault G, Gautrin D, Ghezzo H, Trudeau C, Malo JL.

Am J Rhinol. 2007 Jul-Aug;21(4):474-7.

PMID:
17882918
27.

[Sensitization to Aspergillus fumigatus and functional outcome of asthma].

Benghida R, Ghezzo H, Malo JL.

Rev Mal Respir. 2007 Jan;24(1):23-31. French.

PMID:
17268362
28.

Assessment of impairment/disability due to occupational asthma through a multidimensional approach.

Yacoub MR, Lavoie K, Lacoste G, Daigle S, L'archevêque J, Ghezzo H, Lemière C, Malo JL.

Eur Respir J. 2007 May;29(5):889-96. Epub 2006 Dec 20.

29.

Orthopnea and tidal expiratory flow limitation in chronic heart failure.

Torchio R, Gulotta C, Greco-Lucchina P, Perboni A, Avonto L, Ghezzo H, Milic-Emili J.

Chest. 2006 Aug;130(2):472-9.

PMID:
16899847
30.

Airway hyperresponsiveness and risk of chest symptoms in an occupational model.

Boutet K, Malo JL, Ghezzo H, Gautrin D.

Thorax. 2007 Mar;62(3):260-4. Epub 2006 Aug 7.

31.

Paper stamp checklist tool enhances asthma guidelines knowledge and implementation by primary care physicians.

Renzi PM, Ghezzo H, Goulet S, Dorval E, Thivierge RL.

Can Respir J. 2006 May-Jun;13(4):193-7. Erratum in: Can Respir J. 2006 Jul-Aug;13(5):279.

32.

What are the questionnaire items most useful in identifying subjects with occupational asthma?

Vandenplas O, Ghezzo H, Munoz X, Moscato G, Perfetti L, Lemière C, Labrecque M, L'Archevêque J, Malo JL.

Eur Respir J. 2005 Dec;26(6):1056-63.

33.
34.

The development of emphysema in cigarette smoke-exposed mice is strain dependent.

Guerassimov A, Hoshino Y, Takubo Y, Turcotte A, Yamamoto M, Ghezzo H, Triantafillopoulos A, Whittaker K, Hoidal JR, Cosio MG.

Am J Respir Crit Care Med. 2004 Nov 1;170(9):974-80. Epub 2004 Jul 28.

PMID:
15282203
35.

Recovery of methacholine responsiveness after end of exposure in occupational asthma.

Malo JL, Ghezzo H.

Am J Respir Crit Care Med. 2004 Jun 15;169(12):1304-7. Epub 2004 Apr 7.

PMID:
15070824
36.

Incidence of occupational rhinoconjunctivitis and risk factors in animal-health apprentices.

Rodier F, Gautrin D, Ghezzo H, Malo JL.

J Allergy Clin Immunol. 2003 Dec;112(6):1105-11.

PMID:
14657867
37.

Airway inflammation after cessation of exposure to agents causing occupational asthma.

Maghni K, Lemière C, Ghezzo H, Yuquan W, Malo JL.

Am J Respir Crit Care Med. 2004 Feb 1;169(3):367-72. Epub 2003 Oct 24.

PMID:
14578217
39.

Time course of onset of sensitization to common and occupational inhalants in apprentices.

Nguyen B, Ghezzo H, Malo JL, Gautrin D.

J Allergy Clin Immunol. 2003 Apr;111(4):807-12.

PMID:
12704362
40.

Does clinical trial subject selection restrict the ability to generalize use and cost of health services to "real life" subjects?

Kennedy WA, Laurier C, Malo JL, Ghezzo H, L'Archevêque J, Contandriopoulos AP.

Int J Technol Assess Health Care. 2003 Winter;19(1):8-16.

PMID:
12701935
41.

Alpha1-antitrypsin determines the pattern of emphysema and function in tobacco smoke-exposed mice: parallels with human disease.

Takubo Y, Guerassimov A, Ghezzo H, Triantafillopoulos A, Bates JH, Hoidal JR, Cosio MG.

Am J Respir Crit Care Med. 2002 Dec 15;166(12 Pt 1):1596-603.

PMID:
12471075
42.

Risk factors for bronchial hyperresponsiveness in late childhood and early adolescence.

Ernst P, Ghezzo H, Becklake MR.

Eur Respir J. 2002 Sep;20(3):635-9.

43.

Incidence and host determinants of work-related rhinoconjunctivitis in apprentice pastry-makers.

Gautrin D, Ghezzo H, Infante-Rivard C, Malo JL.

Allergy. 2002 Oct;57(10):913-8.

PMID:
12269937
44.

Tidal expiratory flow limitation and chronic dyspnoea in patients with cystic fibrosis.

Goetghebeur D, Sarni D, Grossi Y, Leroyer C, Ghezzo H, Milic-Emiri J, Bellet M.

Eur Respir J. 2002 Mar;19(3):492-8.

45.

Host determinants for the development of allergy in apprentices exposed to laboratory animals.

Gautrin D, Ghezzo H, Infante-Rivard C, Malo JL.

Eur Respir J. 2002 Jan;19(1):96-103.

46.

Greater velocity and magnitude of airway narrowing in immature than in mature rabbit lung explants.

Duguet A, Wang CG, Gomes R, Ghezzo H, Eidelman DH, Tepper RS.

Am J Respir Crit Care Med. 2001 Nov 1;164(9):1728-33.

PMID:
11719317
47.

Breathing pattern and gas exchange at peak exercise in COPD patients with and without tidal flow limitation at rest.

Díaz O, Villafranca C, Ghezzo H, Borzone G, Leiva A, Milic-Emili J, Lisboa C.

Eur Respir J. 2001 Jun;17(6):1120-7.

48.
49.

Natural history of sensitization, symptoms and occupational diseases in apprentices exposed to laboratory animals.

Gautrin D, Ghezzo H, Infante-Rivard C, Malo JL.

Eur Respir J. 2001 May;17(5):904-8.

50.

Incidence of sensitization, symptoms, and probable occupational rhinoconjunctivitis and asthma in apprentices starting exposure to latex.

Archambault S, Malo JL, Infante-Rivard C, Ghezzo H, Gautrin D.

J Allergy Clin Immunol. 2001 May;107(5):921-3.

PMID:
11344363

Supplemental Content

Loading ...
Support Center